Clinical trial
Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic…
NCT00141362 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00141362 |
|---|---|
| Title | Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain. |
| Official title | An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Chronic Neuropathic Pain. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | Pregabalin |
| Enrollment | 325 |
| Start date | Oct 1, 2001 |
| Completion | Aug 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Jan 1, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: